nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—ABCG2—Leflunomide—systemic lupus erythematosus	0.0733	0.119	CbGbCtD
Mitoxantrone—ABCC1—Cyclosporine—systemic lupus erythematosus	0.0513	0.0831	CbGbCtD
Mitoxantrone—CYP1B1—Dexamethasone—systemic lupus erythematosus	0.0475	0.0771	CbGbCtD
Mitoxantrone—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0453	0.0734	CbGbCtD
Mitoxantrone—CYP2E1—Dapsone—systemic lupus erythematosus	0.0372	0.0604	CbGbCtD
Mitoxantrone—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0363	0.0589	CbGbCtD
Mitoxantrone—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0343	0.0556	CbGbCtD
Mitoxantrone—ABCC1—Methotrexate—systemic lupus erythematosus	0.0271	0.044	CbGbCtD
Mitoxantrone—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0226	0.0366	CbGbCtD
Mitoxantrone—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0215	0.0349	CbGbCtD
Mitoxantrone—ABCG2—Methotrexate—systemic lupus erythematosus	0.0182	0.0294	CbGbCtD
Mitoxantrone—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0163	0.0265	CbGbCtD
Mitoxantrone—CYP2E1—Dexamethasone—systemic lupus erythematosus	0.0161	0.0261	CbGbCtD
Mitoxantrone—ABCB1—Betamethasone—systemic lupus erythematosus	0.014	0.0227	CbGbCtD
Mitoxantrone—ABCB1—Prednisolone—systemic lupus erythematosus	0.0138	0.0224	CbGbCtD
Mitoxantrone—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0131	0.0212	CbGbCtD
Mitoxantrone—ABCB1—Prednisone—systemic lupus erythematosus	0.013	0.0212	CbGbCtD
Mitoxantrone—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0129	0.0209	CbGbCtD
Mitoxantrone—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0124	0.0201	CbGbCtD
Mitoxantrone—CYP3A4—Dapsone—systemic lupus erythematosus	0.0113	0.0183	CbGbCtD
Mitoxantrone—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00978	0.0159	CbGbCtD
Mitoxantrone—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00978	0.0159	CbGbCtD
Mitoxantrone—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00839	0.0136	CbGbCtD
Mitoxantrone—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00828	0.0134	CbGbCtD
Mitoxantrone—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00815	0.0132	CbGbCtD
Mitoxantrone—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00785	0.0127	CbGbCtD
Mitoxantrone—CYP3A4—Prednisone—systemic lupus erythematosus	0.00782	0.0127	CbGbCtD
Mitoxantrone—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00741	0.012	CbGbCtD
Mitoxantrone—ABCB1—Methotrexate—systemic lupus erythematosus	0.00655	0.0106	CbGbCtD
Mitoxantrone—BTK—blood plasma—systemic lupus erythematosus	0.00526	0.0642	CbGeAlD
Mitoxantrone—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00488	0.00792	CbGbCtD
Mitoxantrone—SLC47A2—kidney—systemic lupus erythematosus	0.00316	0.0386	CbGeAlD
Mitoxantrone—SLC47A2—cortex of kidney—systemic lupus erythematosus	0.00308	0.0376	CbGeAlD
Mitoxantrone—BTK—connective tissue—systemic lupus erythematosus	0.0028	0.0342	CbGeAlD
Mitoxantrone—SLC47A2—tendon—systemic lupus erythematosus	0.00255	0.0311	CbGeAlD
Mitoxantrone—PIM1—connective tissue—systemic lupus erythematosus	0.00243	0.0296	CbGeAlD
Mitoxantrone—PIM1—nephron tubule—systemic lupus erythematosus	0.00235	0.0287	CbGeAlD
Mitoxantrone—CYP2E1—urine—systemic lupus erythematosus	0.00221	0.027	CbGeAlD
Mitoxantrone—PIM1—skin of body—systemic lupus erythematosus	0.00219	0.0267	CbGeAlD
Mitoxantrone—SLC47A2—nervous system—systemic lupus erythematosus	0.00207	0.0253	CbGeAlD
Mitoxantrone—PIM1—kidney—systemic lupus erythematosus	0.00206	0.0252	CbGeAlD
Mitoxantrone—BTK—lymphoid tissue—systemic lupus erythematosus	0.00205	0.025	CbGeAlD
Mitoxantrone—PIM1—cortex of kidney—systemic lupus erythematosus	0.00201	0.0245	CbGeAlD
Mitoxantrone—SLC47A2—central nervous system—systemic lupus erythematosus	0.002	0.0244	CbGeAlD
Mitoxantrone—BTK—tendon—systemic lupus erythematosus	0.00192	0.0235	CbGeAlD
Mitoxantrone—BTK—bone marrow—systemic lupus erythematosus	0.00186	0.0228	CbGeAlD
Mitoxantrone—CYP3A4—urine—systemic lupus erythematosus	0.00178	0.0217	CbGeAlD
Mitoxantrone—PIM1—lymphoid tissue—systemic lupus erythematosus	0.00177	0.0216	CbGeAlD
Mitoxantrone—BTK—lung—systemic lupus erythematosus	0.00169	0.0206	CbGeAlD
Mitoxantrone—PIM1—tendon—systemic lupus erythematosus	0.00167	0.0203	CbGeAlD
Mitoxantrone—PIM1—bone marrow—systemic lupus erythematosus	0.00161	0.0197	CbGeAlD
Mitoxantrone—PIM1—lung—systemic lupus erythematosus	0.00146	0.0179	CbGeAlD
Mitoxantrone—PIM1—nervous system—systemic lupus erythematosus	0.00135	0.0165	CbGeAlD
Mitoxantrone—PIM1—central nervous system—systemic lupus erythematosus	0.0013	0.0159	CbGeAlD
Mitoxantrone—SLC47A1—nephron tubule—systemic lupus erythematosus	0.00126	0.0154	CbGeAlD
Mitoxantrone—CYP2E1—blood plasma—systemic lupus erythematosus	0.00115	0.0141	CbGeAlD
Mitoxantrone—SLC47A1—kidney—systemic lupus erythematosus	0.00111	0.0135	CbGeAlD
Mitoxantrone—SLC47A1—cortex of kidney—systemic lupus erythematosus	0.00108	0.0131	CbGeAlD
Mitoxantrone—TOP2A—tendon—systemic lupus erythematosus	0.000978	0.0119	CbGeAlD
Mitoxantrone—CYP1B1—connective tissue—systemic lupus erythematosus	0.000952	0.0116	CbGeAlD
Mitoxantrone—TOP2A—bone marrow—systemic lupus erythematosus	0.000947	0.0116	CbGeAlD
Mitoxantrone—CYP3A4—blood plasma—systemic lupus erythematosus	0.000928	0.0113	CbGeAlD
Mitoxantrone—CYP1B1—nephron tubule—systemic lupus erythematosus	0.000923	0.0113	CbGeAlD
Mitoxantrone—SLC47A1—tendon—systemic lupus erythematosus	0.000893	0.0109	CbGeAlD
Mitoxantrone—CYP1B1—skin of body—systemic lupus erythematosus	0.00086	0.0105	CbGeAlD
Mitoxantrone—TOP2A—lung—systemic lupus erythematosus	0.000858	0.0105	CbGeAlD
Mitoxantrone—CYP1B1—kidney—systemic lupus erythematosus	0.000811	0.0099	CbGeAlD
Mitoxantrone—CYP1B1—cortex of kidney—systemic lupus erythematosus	0.00079	0.00964	CbGeAlD
Mitoxantrone—SLC47A1—lung—systemic lupus erythematosus	0.000784	0.00957	CbGeAlD
Mitoxantrone—SLC47A1—nervous system—systemic lupus erythematosus	0.000726	0.00886	CbGeAlD
Mitoxantrone—ABCC1—cortex of kidney—systemic lupus erythematosus	0.00071	0.00867	CbGeAlD
Mitoxantrone—SLC47A1—central nervous system—systemic lupus erythematosus	0.000699	0.00853	CbGeAlD
Mitoxantrone—CYP1B1—lymphoid tissue—systemic lupus erythematosus	0.000696	0.0085	CbGeAlD
Mitoxantrone—ABCG2—nephron tubule—systemic lupus erythematosus	0.000687	0.00839	CbGeAlD
Mitoxantrone—ABCB1—blood plasma—systemic lupus erythematosus	0.000657	0.00802	CbGeAlD
Mitoxantrone—CYP1B1—tendon—systemic lupus erythematosus	0.000655	0.00799	CbGeAlD
Mitoxantrone—CYP2E1—nephron tubule—systemic lupus erythematosus	0.000595	0.00726	CbGeAlD
Mitoxantrone—ABCC1—tendon—systemic lupus erythematosus	0.000589	0.00719	CbGeAlD
Mitoxantrone—CYP1B1—lung—systemic lupus erythematosus	0.000575	0.00701	CbGeAlD
Mitoxantrone—CYP1B1—nervous system—systemic lupus erythematosus	0.000532	0.00649	CbGeAlD
Mitoxantrone—CYP2E1—kidney—systemic lupus erythematosus	0.000523	0.00638	CbGeAlD
Mitoxantrone—ABCC1—lung—systemic lupus erythematosus	0.000517	0.00631	CbGeAlD
Mitoxantrone—CYP1B1—central nervous system—systemic lupus erythematosus	0.000512	0.00625	CbGeAlD
Mitoxantrone—CYP2E1—cortex of kidney—systemic lupus erythematosus	0.000509	0.00621	CbGeAlD
Mitoxantrone—ABCG2—bone marrow—systemic lupus erythematosus	0.000472	0.00576	CbGeAlD
Mitoxantrone—CYP2E1—lymphoid tissue—systemic lupus erythematosus	0.000449	0.00548	CbGeAlD
Mitoxantrone—ABCG2—lung—systemic lupus erythematosus	0.000428	0.00522	CbGeAlD
Mitoxantrone—CYP2E1—tendon—systemic lupus erythematosus	0.000422	0.00515	CbGeAlD
Mitoxantrone—CYP3A4—kidney—systemic lupus erythematosus	0.000421	0.00513	CbGeAlD
Mitoxantrone—CYP2E1—lung—systemic lupus erythematosus	0.00037	0.00452	CbGeAlD
Mitoxantrone—TOP2A—Methyltestosterone—Hydrocortisone—systemic lupus erythematosus	0.00037	0.258	CbGdCrCtD
Mitoxantrone—CYP2E1—nervous system—systemic lupus erythematosus	0.000343	0.00419	CbGeAlD
Mitoxantrone—ABCB1—nephron tubule—systemic lupus erythematosus	0.000339	0.00414	CbGeAlD
Mitoxantrone—CYP2E1—central nervous system—systemic lupus erythematosus	0.00033	0.00403	CbGeAlD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisone—systemic lupus erythematosus	0.000319	0.222	CbGdCrCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisolone—systemic lupus erythematosus	0.000311	0.217	CbGdCrCtD
Mitoxantrone—ABCB1—kidney—systemic lupus erythematosus	0.000298	0.00363	CbGeAlD
Mitoxantrone—ABCB1—cortex of kidney—systemic lupus erythematosus	0.00029	0.00354	CbGeAlD
Mitoxantrone—CYP3A4—nervous system—systemic lupus erythematosus	0.000276	0.00337	CbGeAlD
Mitoxantrone—CYP3A4—central nervous system—systemic lupus erythematosus	0.000266	0.00324	CbGeAlD
Mitoxantrone—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000256	0.00312	CbGeAlD
Mitoxantrone—TOP2A—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.000241	0.168	CbGdCrCtD
Mitoxantrone—ABCB1—bone marrow—systemic lupus erythematosus	0.000233	0.00284	CbGeAlD
Mitoxantrone—ABCB1—lung—systemic lupus erythematosus	0.000211	0.00257	CbGeAlD
Mitoxantrone—ABCB1—nervous system—systemic lupus erythematosus	0.000195	0.00238	CbGeAlD
Mitoxantrone—TOP2A—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000192	0.134	CbGdCrCtD
Mitoxantrone—ABCB1—central nervous system—systemic lupus erythematosus	0.000188	0.0023	CbGeAlD
Mitoxantrone—Alopecia—Prednisone—systemic lupus erythematosus	0.000125	0.000682	CcSEcCtD
Mitoxantrone—Shock—Methylprednisolone—systemic lupus erythematosus	0.000125	0.000681	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000124	0.000678	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000124	0.000677	CcSEcCtD
Mitoxantrone—Rash—Leflunomide—systemic lupus erythematosus	0.000124	0.000677	CcSEcCtD
Mitoxantrone—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000124	0.000677	CcSEcCtD
Mitoxantrone—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000124	0.000676	CcSEcCtD
Mitoxantrone—Nausea—Azathioprine—systemic lupus erythematosus	0.000124	0.000675	CcSEcCtD
Mitoxantrone—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000124	0.000675	CcSEcCtD
Mitoxantrone—Headache—Leflunomide—systemic lupus erythematosus	0.000123	0.000673	CcSEcCtD
Mitoxantrone—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000123	0.000672	CcSEcCtD
Mitoxantrone—Erythema—Prednisone—systemic lupus erythematosus	0.000123	0.000671	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000123	0.000671	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000123	0.00067	CcSEcCtD
Mitoxantrone—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000123	0.00067	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000123	0.000669	CcSEcCtD
Mitoxantrone—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000122	0.000668	CcSEcCtD
Mitoxantrone—Convulsion—Betamethasone—systemic lupus erythematosus	0.000122	0.000668	CcSEcCtD
Mitoxantrone—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000666	CcSEcCtD
Mitoxantrone—Hypertension—Betamethasone—systemic lupus erythematosus	0.000122	0.000666	CcSEcCtD
Mitoxantrone—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000122	0.000666	CcSEcCtD
Mitoxantrone—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000121	0.000661	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000121	0.000661	CcSEcCtD
Mitoxantrone—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000121	0.000658	CcSEcCtD
Mitoxantrone—Myalgia—Dexamethasone—systemic lupus erythematosus	0.00012	0.000656	CcSEcCtD
Mitoxantrone—Myalgia—Betamethasone—systemic lupus erythematosus	0.00012	0.000656	CcSEcCtD
Mitoxantrone—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.00012	0.000655	CcSEcCtD
Mitoxantrone—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.00012	0.000655	CcSEcCtD
Mitoxantrone—Anxiety—Betamethasone—systemic lupus erythematosus	0.00012	0.000654	CcSEcCtD
Mitoxantrone—Anxiety—Dexamethasone—systemic lupus erythematosus	0.00012	0.000654	CcSEcCtD
Mitoxantrone—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000119	0.000649	CcSEcCtD
Mitoxantrone—Discomfort—Betamethasone—systemic lupus erythematosus	0.000119	0.000649	CcSEcCtD
Mitoxantrone—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000119	0.000648	CcSEcCtD
Mitoxantrone—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000119	0.000648	CcSEcCtD
Mitoxantrone—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000119	0.000647	CcSEcCtD
Mitoxantrone—Pain—Prednisolone—systemic lupus erythematosus	0.000118	0.000645	CcSEcCtD
Mitoxantrone—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000118	0.000645	CcSEcCtD
Mitoxantrone—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000118	0.000645	CcSEcCtD
Mitoxantrone—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.000642	CcSEcCtD
Mitoxantrone—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000117	0.00064	CcSEcCtD
Mitoxantrone—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000117	0.00064	CcSEcCtD
Mitoxantrone—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.000639	CcSEcCtD
Mitoxantrone—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.000639	CcSEcCtD
Mitoxantrone—Nausea—Leflunomide—systemic lupus erythematosus	0.000117	0.000638	CcSEcCtD
Mitoxantrone—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000116	0.000635	CcSEcCtD
Mitoxantrone—Vision blurred—Prednisone—systemic lupus erythematosus	0.000116	0.000633	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000116	0.000632	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000116	0.00063	CcSEcCtD
Mitoxantrone—Pain—Hydrocortisone—systemic lupus erythematosus	0.000115	0.00063	CcSEcCtD
Mitoxantrone—Oedema—Betamethasone—systemic lupus erythematosus	0.000115	0.000629	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000115	0.000629	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000115	0.000629	CcSEcCtD
Mitoxantrone—Oedema—Dexamethasone—systemic lupus erythematosus	0.000115	0.000629	CcSEcCtD
Mitoxantrone—Infection—Betamethasone—systemic lupus erythematosus	0.000115	0.000625	CcSEcCtD
Mitoxantrone—Infection—Dexamethasone—systemic lupus erythematosus	0.000115	0.000625	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000114	0.000623	CcSEcCtD
Mitoxantrone—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000114	0.000623	CcSEcCtD
Mitoxantrone—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000114	0.000621	CcSEcCtD
Mitoxantrone—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000114	0.000621	CcSEcCtD
Mitoxantrone—Anaemia—Prednisone—systemic lupus erythematosus	0.000114	0.000621	CcSEcCtD
Mitoxantrone—Shock—Dexamethasone—systemic lupus erythematosus	0.000113	0.000619	CcSEcCtD
Mitoxantrone—Shock—Betamethasone—systemic lupus erythematosus	0.000113	0.000619	CcSEcCtD
Mitoxantrone—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000113	0.000618	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000113	0.000616	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000113	0.000616	CcSEcCtD
Mitoxantrone—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000113	0.000614	CcSEcCtD
Mitoxantrone—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000113	0.000614	CcSEcCtD
Mitoxantrone—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000112	0.000611	CcSEcCtD
Mitoxantrone—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000112	0.00061	CcSEcCtD
Mitoxantrone—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000112	0.000609	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000112	0.000608	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000112	0.000608	CcSEcCtD
Mitoxantrone—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000111	0.000607	CcSEcCtD
Mitoxantrone—Malaise—Prednisone—systemic lupus erythematosus	0.000111	0.000606	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.00011	0.000602	CcSEcCtD
Mitoxantrone—BTK—Immune System—XRCC6—systemic lupus erythematosus	0.00011	0.000945	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	0.00011	0.000944	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—CDKN1B—systemic lupus erythematosus	0.00011	0.000943	CbGpPWpGaD
Mitoxantrone—Anorexia—Dexamethasone—systemic lupus erythematosus	0.00011	0.0006	CcSEcCtD
Mitoxantrone—Anorexia—Betamethasone—systemic lupus erythematosus	0.00011	0.0006	CcSEcCtD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.00011	0.000941	CbGpPWpGaD
Mitoxantrone—Urticaria—Prednisolone—systemic lupus erythematosus	0.00011	0.000599	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	0.00011	0.00094	CbGpPWpGaD
Mitoxantrone—Fatigue—Triamcinolone—systemic lupus erythematosus	0.00011	0.000598	CcSEcCtD
Mitoxantrone—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000597	CcSEcCtD
Mitoxantrone—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000109	0.000596	CcSEcCtD
Mitoxantrone—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000109	0.000595	CcSEcCtD
Mitoxantrone—Pain—Triamcinolone—systemic lupus erythematosus	0.000109	0.000593	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	0.000108	0.000928	CbGpPWpGaD
Mitoxantrone—Hypotension—Betamethasone—systemic lupus erythematosus	0.000108	0.000588	CcSEcCtD
Mitoxantrone—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000108	0.000588	CcSEcCtD
Mitoxantrone—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000585	CcSEcCtD
Mitoxantrone—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000582	CcSEcCtD
Mitoxantrone—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000582	CcSEcCtD
Mitoxantrone—Convulsion—Prednisone—systemic lupus erythematosus	0.000107	0.000582	CcSEcCtD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	0.000106	0.000911	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.000106	0.000911	CbGpPWpGaD
Mitoxantrone—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.00058	CcSEcCtD
Mitoxantrone—Hypertension—Prednisone—systemic lupus erythematosus	0.000106	0.00058	CcSEcCtD
Mitoxantrone—Chills—Methotrexate—systemic lupus erythematosus	0.000106	0.000578	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000105	0.000573	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000105	0.000573	CcSEcCtD
Mitoxantrone—Arthralgia—Prednisone—systemic lupus erythematosus	0.000105	0.000572	CcSEcCtD
Mitoxantrone—Myalgia—Prednisone—systemic lupus erythematosus	0.000105	0.000572	CcSEcCtD
Mitoxantrone—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000105	0.000572	CcSEcCtD
Mitoxantrone—BTK—Immune System—CR1—systemic lupus erythematosus	0.000105	0.000895	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	0.000105	0.000895	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000105	0.00057	CcSEcCtD
Mitoxantrone—Anxiety—Prednisone—systemic lupus erythematosus	0.000104	0.00057	CcSEcCtD
Mitoxantrone—Alopecia—Methotrexate—systemic lupus erythematosus	0.000104	0.00057	CcSEcCtD
Mitoxantrone—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000104	0.000567	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000104	0.000566	CcSEcCtD
Mitoxantrone—BTK—DAP12 interactions—CDKN1B—systemic lupus erythematosus	0.000104	0.000887	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—CDKN1B—systemic lupus erythematosus	0.000104	0.000887	CbGpPWpGaD
Mitoxantrone—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000104	0.000565	CcSEcCtD
Mitoxantrone—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000104	0.000565	CcSEcCtD
Mitoxantrone—Discomfort—Prednisone—systemic lupus erythematosus	0.000104	0.000565	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	0.000103	0.000885	CbGpPWpGaD
Mitoxantrone—Erythema—Methotrexate—systemic lupus erythematosus	0.000103	0.000561	CcSEcCtD
Mitoxantrone—TOP2A—Circadian rythm related genes—FAS—systemic lupus erythematosus	0.000102	0.000875	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	0.000102	0.000872	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000102	0.000556	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—CDKN1A—systemic lupus erythematosus	0.000102	0.00087	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PTPRC—systemic lupus erythematosus	0.000102	0.00087	CbGpPWpGaD
Mitoxantrone—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000102	0.000554	CcSEcCtD
Mitoxantrone—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000102	0.000554	CcSEcCtD
Mitoxantrone—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000101	0.000553	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	0.000101	0.000866	CbGpPWpGaD
Mitoxantrone—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000101	0.000551	CcSEcCtD
Mitoxantrone—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000101	0.00055	CcSEcCtD
Mitoxantrone—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000101	0.00055	CcSEcCtD
Mitoxantrone—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000101	0.000548	CcSEcCtD
Mitoxantrone—Oedema—Prednisone—systemic lupus erythematosus	0.0001	0.000548	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.0001	0.000548	CcSEcCtD
Mitoxantrone—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.0001	0.000547	CcSEcCtD
Mitoxantrone—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.0001	0.000547	CcSEcCtD
Mitoxantrone—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.0001	0.000547	CcSEcCtD
Mitoxantrone—Infection—Prednisone—systemic lupus erythematosus	9.98e-05	0.000544	CcSEcCtD
Mitoxantrone—BTK—Immune System—TLR6—systemic lupus erythematosus	9.98e-05	0.000854	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CFB—systemic lupus erythematosus	9.98e-05	0.000854	CbGpPWpGaD
Mitoxantrone—Back pain—Methotrexate—systemic lupus erythematosus	9.95e-05	0.000543	CcSEcCtD
Mitoxantrone—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	9.95e-05	0.000543	CcSEcCtD
Mitoxantrone—Fatigue—Betamethasone—systemic lupus erythematosus	9.95e-05	0.000543	CcSEcCtD
Mitoxantrone—Fatigue—Dexamethasone—systemic lupus erythematosus	9.95e-05	0.000543	CcSEcCtD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—IL6—systemic lupus erythematosus	9.89e-05	0.000847	CbGpPWpGaD
Mitoxantrone—Shock—Prednisone—systemic lupus erythematosus	9.88e-05	0.000539	CcSEcCtD
Mitoxantrone—Pain—Dexamethasone—systemic lupus erythematosus	9.87e-05	0.000538	CcSEcCtD
Mitoxantrone—Pain—Betamethasone—systemic lupus erythematosus	9.87e-05	0.000538	CcSEcCtD
Mitoxantrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	9.85e-05	0.000843	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.84e-05	0.000842	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—RXRA—systemic lupus erythematosus	9.81e-05	0.00084	CbGpPWpGaD
Mitoxantrone—Tachycardia—Prednisone—systemic lupus erythematosus	9.81e-05	0.000535	CcSEcCtD
Mitoxantrone—Skin disorder—Prednisone—systemic lupus erythematosus	9.76e-05	0.000532	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Prednisone—systemic lupus erythematosus	9.71e-05	0.00053	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—HMGB1—systemic lupus erythematosus	9.7e-05	0.00083	CbGpPWpGaD
Mitoxantrone—Vision blurred—Methotrexate—systemic lupus erythematosus	9.7e-05	0.000529	CcSEcCtD
Mitoxantrone—Asthenia—Hydrocortisone—systemic lupus erythematosus	9.69e-05	0.000528	CcSEcCtD
Mitoxantrone—Vomiting—Cyclosporine—systemic lupus erythematosus	9.66e-05	0.000527	CcSEcCtD
Mitoxantrone—BTK—B Cell Activation—CDKN1B—systemic lupus erythematosus	9.59e-05	0.000821	CbGpPWpGaD
Mitoxantrone—Rash—Cyclosporine—systemic lupus erythematosus	9.58e-05	0.000523	CcSEcCtD
Mitoxantrone—Anorexia—Prednisone—systemic lupus erythematosus	9.58e-05	0.000522	CcSEcCtD
Mitoxantrone—Dermatitis—Cyclosporine—systemic lupus erythematosus	9.57e-05	0.000522	CcSEcCtD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—CDKN1A—systemic lupus erythematosus	9.57e-05	0.000819	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—CDKN1A—systemic lupus erythematosus	9.57e-05	0.000819	CbGpPWpGaD
Mitoxantrone—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	9.55e-05	0.000521	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—IFNA1—systemic lupus erythematosus	9.53e-05	0.000816	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	9.52e-05	0.000815	CbGpPWpGaD
Mitoxantrone—Headache—Cyclosporine—systemic lupus erythematosus	9.52e-05	0.000519	CcSEcCtD
Mitoxantrone—Anaemia—Methotrexate—systemic lupus erythematosus	9.51e-05	0.000519	CcSEcCtD
Mitoxantrone—Feeling abnormal—Betamethasone—systemic lupus erythematosus	9.51e-05	0.000519	CcSEcCtD
Mitoxantrone—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	9.51e-05	0.000519	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	9.45e-05	0.000809	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	9.45e-05	0.000809	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD40—systemic lupus erythematosus	9.45e-05	0.000809	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	9.43e-05	0.000515	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	9.43e-05	0.000515	CcSEcCtD
Mitoxantrone—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	9.42e-05	0.000514	CcSEcCtD
Mitoxantrone—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	9.37e-05	0.000511	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	9.35e-05	0.00051	CcSEcCtD
Mitoxantrone—Rash—Mycophenolate mofetil—systemic lupus erythematosus	9.35e-05	0.00051	CcSEcCtD
Mitoxantrone—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	9.34e-05	0.000509	CcSEcCtD
Mitoxantrone—BTK—Immune System—FCGR3A—systemic lupus erythematosus	9.32e-05	0.000798	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CTLA4—systemic lupus erythematosus	9.31e-05	0.000797	CbGpPWpGaD
Mitoxantrone—Headache—Mycophenolate mofetil—systemic lupus erythematosus	9.29e-05	0.000506	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—RASGRP1—systemic lupus erythematosus	9.28e-05	0.000795	CbGpPWpGaD
Mitoxantrone—Malaise—Methotrexate—systemic lupus erythematosus	9.28e-05	0.000506	CcSEcCtD
Mitoxantrone—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	9.24e-05	0.000504	CcSEcCtD
Mitoxantrone—BTK—Immune System—RIPK1—systemic lupus erythematosus	9.21e-05	0.000788	CbGpPWpGaD
Mitoxantrone—Leukopenia—Methotrexate—systemic lupus erythematosus	9.21e-05	0.000502	CcSEcCtD
Mitoxantrone—Urticaria—Betamethasone—systemic lupus erythematosus	9.16e-05	0.0005	CcSEcCtD
Mitoxantrone—Urticaria—Dexamethasone—systemic lupus erythematosus	9.16e-05	0.0005	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	9.15e-05	0.000499	CcSEcCtD
Mitoxantrone—Asthenia—Triamcinolone—systemic lupus erythematosus	9.12e-05	0.000498	CcSEcCtD
Mitoxantrone—Body temperature increased—Betamethasone—systemic lupus erythematosus	9.12e-05	0.000497	CcSEcCtD
Mitoxantrone—Abdominal pain—Dexamethasone—systemic lupus erythematosus	9.12e-05	0.000497	CcSEcCtD
Mitoxantrone—Body temperature increased—Dexamethasone—systemic lupus erythematosus	9.12e-05	0.000497	CcSEcCtD
Mitoxantrone—Abdominal pain—Betamethasone—systemic lupus erythematosus	9.12e-05	0.000497	CcSEcCtD
Mitoxantrone—Asthenia—Methylprednisolone—systemic lupus erythematosus	9.1e-05	0.000496	CcSEcCtD
Mitoxantrone—Nausea—Cyclosporine—systemic lupus erythematosus	9.02e-05	0.000492	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisone—systemic lupus erythematosus	9.02e-05	0.000492	CcSEcCtD
Mitoxantrone—Cough—Methotrexate—systemic lupus erythematosus	8.98e-05	0.00049	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	8.97e-05	0.000768	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TNF—systemic lupus erythematosus	8.96e-05	0.000767	CbGpPWpGaD
Mitoxantrone—Convulsion—Methotrexate—systemic lupus erythematosus	8.91e-05	0.000486	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—RASGRP1—systemic lupus erythematosus	8.91e-05	0.000763	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TLR9—systemic lupus erythematosus	8.89e-05	0.000761	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD79A—systemic lupus erythematosus	8.88e-05	0.000761	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—CDKN1A—systemic lupus erythematosus	8.85e-05	0.000758	CbGpPWpGaD
Mitoxantrone—Dyspepsia—Prednisone—systemic lupus erythematosus	8.84e-05	0.000482	CcSEcCtD
Mitoxantrone—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	8.8e-05	0.00048	CcSEcCtD
Mitoxantrone—Arthralgia—Methotrexate—systemic lupus erythematosus	8.76e-05	0.000478	CcSEcCtD
Mitoxantrone—Myalgia—Methotrexate—systemic lupus erythematosus	8.76e-05	0.000478	CcSEcCtD
Mitoxantrone—Chest pain—Methotrexate—systemic lupus erythematosus	8.76e-05	0.000478	CcSEcCtD
Mitoxantrone—Decreased appetite—Prednisone—systemic lupus erythematosus	8.73e-05	0.000476	CcSEcCtD
Mitoxantrone—Rash—Prednisolone—systemic lupus erythematosus	8.72e-05	0.000476	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisolone—systemic lupus erythematosus	8.71e-05	0.000475	CcSEcCtD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—systemic lupus erythematosus	8.69e-05	0.000744	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	8.68e-05	0.000473	CcSEcCtD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.67e-05	0.000742	CbGpPWpGaD
Mitoxantrone—Fatigue—Prednisone—systemic lupus erythematosus	8.66e-05	0.000472	CcSEcCtD
Mitoxantrone—Headache—Prednisolone—systemic lupus erythematosus	8.66e-05	0.000472	CcSEcCtD
Mitoxantrone—Discomfort—Methotrexate—systemic lupus erythematosus	8.65e-05	0.000472	CcSEcCtD
Mitoxantrone—Constipation—Prednisone—systemic lupus erythematosus	8.59e-05	0.000469	CcSEcCtD
Mitoxantrone—Vomiting—Hydrocortisone—systemic lupus erythematosus	8.59e-05	0.000468	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—IL6—systemic lupus erythematosus	8.54e-05	0.000731	CbGpPWpGaD
Mitoxantrone—Rash—Hydrocortisone—systemic lupus erythematosus	8.51e-05	0.000464	CcSEcCtD
Mitoxantrone—Dermatitis—Hydrocortisone—systemic lupus erythematosus	8.51e-05	0.000464	CcSEcCtD
Mitoxantrone—Confusional state—Methotrexate—systemic lupus erythematosus	8.47e-05	0.000462	CcSEcCtD
Mitoxantrone—Headache—Hydrocortisone—systemic lupus erythematosus	8.46e-05	0.000461	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	8.4e-05	0.000458	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	8.39e-05	0.000718	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	8.37e-05	0.000717	CbGpPWpGaD
Mitoxantrone—Infection—Methotrexate—systemic lupus erythematosus	8.34e-05	0.000455	CcSEcCtD
Mitoxantrone—Feeling abnormal—Prednisone—systemic lupus erythematosus	8.28e-05	0.000452	CcSEcCtD
Mitoxantrone—Asthenia—Dexamethasone—systemic lupus erythematosus	8.28e-05	0.000452	CcSEcCtD
Mitoxantrone—Asthenia—Betamethasone—systemic lupus erythematosus	8.28e-05	0.000452	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	8.22e-05	0.000448	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	8.22e-05	0.000448	CcSEcCtD
Mitoxantrone—Nausea—Prednisolone—systemic lupus erythematosus	8.21e-05	0.000448	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—HLA-DQA1—systemic lupus erythematosus	8.2e-05	0.000702	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—PPARG—systemic lupus erythematosus	8.17e-05	0.000699	CbGpPWpGaD
Mitoxantrone—Skin disorder—Methotrexate—systemic lupus erythematosus	8.16e-05	0.000445	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	8.12e-05	0.000443	CcSEcCtD
Mitoxantrone—Vomiting—Triamcinolone—systemic lupus erythematosus	8.08e-05	0.000441	CcSEcCtD
Mitoxantrone—Vomiting—Methylprednisolone—systemic lupus erythematosus	8.07e-05	0.00044	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—IL6—systemic lupus erythematosus	8.03e-05	0.000687	CbGpPWpGaD
Mitoxantrone—Nausea—Hydrocortisone—systemic lupus erythematosus	8.02e-05	0.000438	CcSEcCtD
Mitoxantrone—Rash—Triamcinolone—systemic lupus erythematosus	8.02e-05	0.000437	CcSEcCtD
Mitoxantrone—Dermatitis—Triamcinolone—systemic lupus erythematosus	8.01e-05	0.000437	CcSEcCtD
Mitoxantrone—Anorexia—Methotrexate—systemic lupus erythematosus	8e-05	0.000437	CcSEcCtD
Mitoxantrone—Rash—Methylprednisolone—systemic lupus erythematosus	8e-05	0.000436	CcSEcCtD
Mitoxantrone—Dermatitis—Methylprednisolone—systemic lupus erythematosus	7.99e-05	0.000436	CcSEcCtD
Mitoxantrone—Urticaria—Prednisone—systemic lupus erythematosus	7.98e-05	0.000435	CcSEcCtD
Mitoxantrone—Headache—Triamcinolone—systemic lupus erythematosus	7.97e-05	0.000434	CcSEcCtD
Mitoxantrone—Headache—Methylprednisolone—systemic lupus erythematosus	7.95e-05	0.000434	CcSEcCtD
Mitoxantrone—Body temperature increased—Prednisone—systemic lupus erythematosus	7.94e-05	0.000433	CcSEcCtD
Mitoxantrone—Abdominal pain—Prednisone—systemic lupus erythematosus	7.94e-05	0.000433	CcSEcCtD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	7.94e-05	0.000679	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CSK—systemic lupus erythematosus	7.93e-05	0.000679	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	7.92e-05	0.000678	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	7.92e-05	0.000678	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Betamethasone—systemic lupus erythematosus	7.89e-05	0.000431	CcSEcCtD
Mitoxantrone—Diarrhoea—Dexamethasone—systemic lupus erythematosus	7.89e-05	0.000431	CcSEcCtD
Mitoxantrone—BTK—Immune System—MBL2—systemic lupus erythematosus	7.86e-05	0.000673	CbGpPWpGaD
Mitoxantrone—Hypotension—Methotrexate—systemic lupus erythematosus	7.85e-05	0.000428	CcSEcCtD
Mitoxantrone—BTK—Immune System—IRF5—systemic lupus erythematosus	7.8e-05	0.000668	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	7.72e-05	0.000661	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	7.71e-05	0.00066	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HLA-DQB1—systemic lupus erythematosus	7.67e-05	0.000657	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	7.65e-05	0.000417	CcSEcCtD
Mitoxantrone—Nausea—Triamcinolone—systemic lupus erythematosus	7.55e-05	0.000412	CcSEcCtD
Mitoxantrone—Paraesthesia—Methotrexate—systemic lupus erythematosus	7.54e-05	0.000411	CcSEcCtD
Mitoxantrone—Nausea—Methylprednisolone—systemic lupus erythematosus	7.54e-05	0.000411	CcSEcCtD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	7.52e-05	0.000643	CbGpPWpGaD
Mitoxantrone—Dyspnoea—Methotrexate—systemic lupus erythematosus	7.49e-05	0.000408	CcSEcCtD
Mitoxantrone—Somnolence—Methotrexate—systemic lupus erythematosus	7.46e-05	0.000407	CcSEcCtD
Mitoxantrone—BTK—Immune System—IRF8—systemic lupus erythematosus	7.45e-05	0.000638	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ITGAM—systemic lupus erythematosus	7.45e-05	0.000638	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IFIH1—systemic lupus erythematosus	7.45e-05	0.000638	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD247—systemic lupus erythematosus	7.45e-05	0.000638	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Prednisone—systemic lupus erythematosus	7.4e-05	0.000404	CcSEcCtD
Mitoxantrone—Dyspepsia—Methotrexate—systemic lupus erythematosus	7.39e-05	0.000403	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	7.37e-05	0.000631	CbGpPWpGaD
Mitoxantrone—Vomiting—Dexamethasone—systemic lupus erythematosus	7.34e-05	0.0004	CcSEcCtD
Mitoxantrone—Vomiting—Betamethasone—systemic lupus erythematosus	7.34e-05	0.0004	CcSEcCtD
Mitoxantrone—Decreased appetite—Methotrexate—systemic lupus erythematosus	7.3e-05	0.000398	CcSEcCtD
Mitoxantrone—Rash—Betamethasone—systemic lupus erythematosus	7.27e-05	0.000397	CcSEcCtD
Mitoxantrone—Rash—Dexamethasone—systemic lupus erythematosus	7.27e-05	0.000397	CcSEcCtD
Mitoxantrone—Dermatitis—Dexamethasone—systemic lupus erythematosus	7.27e-05	0.000396	CcSEcCtD
Mitoxantrone—Dermatitis—Betamethasone—systemic lupus erythematosus	7.27e-05	0.000396	CcSEcCtD
Mitoxantrone—BTK—Immune System—NCF2—systemic lupus erythematosus	7.25e-05	0.000621	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD40LG—systemic lupus erythematosus	7.24e-05	0.00062	CbGpPWpGaD
Mitoxantrone—Fatigue—Methotrexate—systemic lupus erythematosus	7.24e-05	0.000395	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL6—systemic lupus erythematosus	7.23e-05	0.000619	CbGpPWpGaD
Mitoxantrone—Headache—Dexamethasone—systemic lupus erythematosus	7.23e-05	0.000394	CcSEcCtD
Mitoxantrone—Headache—Betamethasone—systemic lupus erythematosus	7.23e-05	0.000394	CcSEcCtD
Mitoxantrone—Asthenia—Prednisone—systemic lupus erythematosus	7.21e-05	0.000393	CcSEcCtD
Mitoxantrone—BTK—Immune System—LYN—systemic lupus erythematosus	7.2e-05	0.000617	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—JAK1—systemic lupus erythematosus	7.2e-05	0.000616	CbGpPWpGaD
Mitoxantrone—Pain—Methotrexate—systemic lupus erythematosus	7.18e-05	0.000392	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—CD8A—systemic lupus erythematosus	7.16e-05	0.000613	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—IL6—systemic lupus erythematosus	7.15e-05	0.000612	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FCGR2A—systemic lupus erythematosus	7.11e-05	0.000609	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	7.1e-05	0.000608	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	7.06e-05	0.000605	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	7e-05	0.0006	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TNFAIP3—systemic lupus erythematosus	6.98e-05	0.000597	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	6.92e-05	0.000593	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Methotrexate—systemic lupus erythematosus	6.92e-05	0.000377	CcSEcCtD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	6.91e-05	0.000591	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BLK—systemic lupus erythematosus	6.9e-05	0.00059	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Prednisone—systemic lupus erythematosus	6.87e-05	0.000375	CcSEcCtD
Mitoxantrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	6.87e-05	0.000588	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	6.87e-05	0.000375	CcSEcCtD
Mitoxantrone—Nausea—Betamethasone—systemic lupus erythematosus	6.85e-05	0.000374	CcSEcCtD
Mitoxantrone—Nausea—Dexamethasone—systemic lupus erythematosus	6.85e-05	0.000374	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	6.7e-05	0.000573	CbGpPWpGaD
Mitoxantrone—Urticaria—Methotrexate—systemic lupus erythematosus	6.67e-05	0.000364	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—C3—systemic lupus erythematosus	6.67e-05	0.000571	CbGpPWpGaD
Mitoxantrone—Body temperature increased—Methotrexate—systemic lupus erythematosus	6.64e-05	0.000362	CcSEcCtD
Mitoxantrone—Abdominal pain—Methotrexate—systemic lupus erythematosus	6.64e-05	0.000362	CcSEcCtD
Mitoxantrone—CYP2E1—Biological oxidations—RXRA—systemic lupus erythematosus	6.41e-05	0.000549	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—C3—systemic lupus erythematosus	6.4e-05	0.000548	CbGpPWpGaD
Mitoxantrone—Vomiting—Prednisone—systemic lupus erythematosus	6.39e-05	0.000348	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	6.38e-05	0.000546	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	6.34e-05	0.000543	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CRP—systemic lupus erythematosus	6.34e-05	0.000543	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—IL6—systemic lupus erythematosus	6.34e-05	0.000542	CbGpPWpGaD
Mitoxantrone—Rash—Prednisone—systemic lupus erythematosus	6.33e-05	0.000346	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisone—systemic lupus erythematosus	6.33e-05	0.000345	CcSEcCtD
Mitoxantrone—Headache—Prednisone—systemic lupus erythematosus	6.29e-05	0.000343	CcSEcCtD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	6.2e-05	0.000531	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Methotrexate—systemic lupus erythematosus	6.19e-05	0.000337	CcSEcCtD
Mitoxantrone—BTK—Immune System—PTPRC—systemic lupus erythematosus	6.17e-05	0.000528	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1RN—systemic lupus erythematosus	6.14e-05	0.000525	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—TLR4—systemic lupus erythematosus	6.08e-05	0.00052	CbGpPWpGaD
Mitoxantrone—Asthenia—Methotrexate—systemic lupus erythematosus	6.02e-05	0.000329	CcSEcCtD
Mitoxantrone—Nausea—Prednisone—systemic lupus erythematosus	5.97e-05	0.000326	CcSEcCtD
Mitoxantrone—BTK—DAP12 interactions—IL6—systemic lupus erythematosus	5.96e-05	0.00051	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	5.96e-05	0.00051	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	5.89e-05	0.000505	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	5.85e-05	0.000501	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	5.83e-05	0.000499	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.74e-05	0.000313	CcSEcCtD
Mitoxantrone—BTK—Immune System—CD40—systemic lupus erythematosus	5.73e-05	0.000491	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CTLA4—systemic lupus erythematosus	5.65e-05	0.000484	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HMGB1—systemic lupus erythematosus	5.65e-05	0.000484	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CD80—systemic lupus erythematosus	5.61e-05	0.00048	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	5.6e-05	0.000479	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.59e-05	0.000478	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	5.57e-05	0.000477	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IFNA1—systemic lupus erythematosus	5.55e-05	0.000475	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RASGRP1—systemic lupus erythematosus	5.41e-05	0.000463	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD79A—systemic lupus erythematosus	5.39e-05	0.000461	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD80—systemic lupus erythematosus	5.39e-05	0.000461	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	5.37e-05	0.00046	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—EP300—systemic lupus erythematosus	5.35e-05	0.000458	CbGpPWpGaD
Mitoxantrone—Vomiting—Methotrexate—systemic lupus erythematosus	5.34e-05	0.000291	CcSEcCtD
Mitoxantrone—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	5.3e-05	0.000454	CbGpPWpGaD
Mitoxantrone—Rash—Methotrexate—systemic lupus erythematosus	5.29e-05	0.000289	CcSEcCtD
Mitoxantrone—Dermatitis—Methotrexate—systemic lupus erythematosus	5.29e-05	0.000289	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	5.27e-05	0.000451	CbGpPWpGaD
Mitoxantrone—Headache—Methotrexate—systemic lupus erythematosus	5.26e-05	0.000287	CcSEcCtD
Mitoxantrone—BTK—Immune System—PRL—systemic lupus erythematosus	5.24e-05	0.000449	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5.23e-05	0.000448	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	5.06e-05	0.000434	CbGpPWpGaD
Mitoxantrone—Nausea—Methotrexate—systemic lupus erythematosus	4.99e-05	0.000272	CcSEcCtD
Mitoxantrone—BTK—Immune System—HLA-DQA1—systemic lupus erythematosus	4.97e-05	0.000426	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	4.84e-05	0.000414	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—TYK2—systemic lupus erythematosus	4.74e-05	0.000405	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	4.66e-05	0.000399	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-DQB1—systemic lupus erythematosus	4.65e-05	0.000398	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—XRCC6—systemic lupus erythematosus	4.58e-05	0.000392	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	4.52e-05	0.000387	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	4.44e-05	0.00038	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL18—systemic lupus erythematosus	4.41e-05	0.000378	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD40LG—systemic lupus erythematosus	4.39e-05	0.000376	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD8A—systemic lupus erythematosus	4.34e-05	0.000372	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	4.29e-05	0.000367	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CD4—systemic lupus erythematosus	4.28e-05	0.000367	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—JAK1—systemic lupus erythematosus	4.19e-05	0.000359	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	4.14e-05	0.000354	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD4—systemic lupus erythematosus	4.11e-05	0.000352	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	4.06e-05	0.000348	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CDKN1B—systemic lupus erythematosus	4.03e-05	0.000345	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2RA—systemic lupus erythematosus	3.92e-05	0.000335	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.9e-05	0.000334	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—C3—systemic lupus erythematosus	3.88e-05	0.000332	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	3.87e-05	0.000331	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.77e-05	0.000323	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CDKN1A—systemic lupus erythematosus	3.72e-05	0.000318	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.7e-05	0.000317	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CRP—systemic lupus erythematosus	3.69e-05	0.000316	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.64e-05	0.000311	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	3.57e-05	0.000306	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TLR4—systemic lupus erythematosus	3.54e-05	0.000303	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-DRB1—systemic lupus erythematosus	3.54e-05	0.000303	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EP300—systemic lupus erythematosus	3.54e-05	0.000303	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	3.52e-05	0.000301	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.51e-05	0.0003	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—IL6—systemic lupus erythematosus	3.5e-05	0.0003	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HIST2H2AC—systemic lupus erythematosus	3.38e-05	0.000289	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CSK—systemic lupus erythematosus	3.29e-05	0.000282	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD80—systemic lupus erythematosus	3.27e-05	0.00028	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.26e-05	0.000279	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	3.23e-05	0.000276	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD247—systemic lupus erythematosus	3.1e-05	0.000265	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NAT2—systemic lupus erythematosus	3.09e-05	0.000265	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	3.07e-05	0.000263	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	3.02e-05	0.000258	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NCF2—systemic lupus erythematosus	3.01e-05	0.000258	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NAT2—systemic lupus erythematosus	2.99e-05	0.000256	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	2.97e-05	0.000255	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	2.83e-05	0.000243	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TYK2—systemic lupus erythematosus	2.76e-05	0.000236	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN1B—systemic lupus erythematosus	2.74e-05	0.000235	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	2.72e-05	0.000233	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	2.7e-05	0.000231	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IFNG—systemic lupus erythematosus	2.58e-05	0.000221	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN1A—systemic lupus erythematosus	2.53e-05	0.000217	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD4—systemic lupus erythematosus	2.49e-05	0.000214	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.46e-05	0.000211	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—EP300—systemic lupus erythematosus	2.41e-05	0.000206	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.38e-05	0.000204	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JUNB—systemic lupus erythematosus	2.36e-05	0.000202	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1B—systemic lupus erythematosus	2.35e-05	0.000201	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—systemic lupus erythematosus	2.32e-05	0.000198	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2—systemic lupus erythematosus	2.3e-05	0.000197	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.21e-05	0.000189	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.2e-05	0.000189	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PRL—systemic lupus erythematosus	2.18e-05	0.000186	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1A—systemic lupus erythematosus	2.16e-05	0.000185	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.14e-05	0.000183	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.1e-05	0.00018	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.09e-05	0.000179	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EP300—systemic lupus erythematosus	2.06e-05	0.000176	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NAT2—systemic lupus erythematosus	1.96e-05	0.000167	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.94e-05	0.000166	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.93e-05	0.000165	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.87e-05	0.00016	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.85e-05	0.000158	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.83e-05	0.000157	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.76e-05	0.000151	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JAK1—systemic lupus erythematosus	1.74e-05	0.000149	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.74e-05	0.000149	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—RXRA—systemic lupus erythematosus	1.74e-05	0.000149	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—RXRA—systemic lupus erythematosus	1.68e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CCR5—systemic lupus erythematosus	1.65e-05	0.000141	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.61e-05	0.000138	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.59e-05	0.000136	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.56e-05	0.000133	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	1.53e-05	0.000131	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.49e-05	0.000127	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.47e-05	0.000126	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD80—systemic lupus erythematosus	1.36e-05	0.000116	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—systemic lupus erythematosus	1.35e-05	0.000116	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TYK2—systemic lupus erythematosus	1.15e-05	9.81e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS3—systemic lupus erythematosus	1.13e-05	9.63e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—RXRA—systemic lupus erythematosus	1.1e-05	9.38e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARG—systemic lupus erythematosus	1.1e-05	9.38e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARG—systemic lupus erythematosus	1.06e-05	9.07e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD4—systemic lupus erythematosus	1.04e-05	8.87e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—systemic lupus erythematosus	1.03e-05	8.81e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1e-05	8.57e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—systemic lupus erythematosus	9.85e-06	8.43e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1B—systemic lupus erythematosus	9.75e-06	8.34e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	9.64e-06	8.25e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—systemic lupus erythematosus	9.53e-06	8.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NOS3—systemic lupus erythematosus	9.42e-06	8.07e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NOS3—systemic lupus erythematosus	9.11e-06	7.8e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	9.07e-06	7.77e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1A—systemic lupus erythematosus	8.99e-06	7.7e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—systemic lupus erythematosus	8.67e-06	7.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—systemic lupus erythematosus	8.62e-06	7.38e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EP300—systemic lupus erythematosus	8.56e-06	7.33e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—systemic lupus erythematosus	8.33e-06	7.14e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	8.29e-06	7.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	8.25e-06	7.07e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	7.58e-06	6.49e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—systemic lupus erythematosus	7.44e-06	6.37e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—EP300—systemic lupus erythematosus	7.17e-06	6.14e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—EP300—systemic lupus erythematosus	6.93e-06	5.93e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARG—systemic lupus erythematosus	6.92e-06	5.92e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—EP300—systemic lupus erythematosus	6.31e-06	5.4e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—systemic lupus erythematosus	6.22e-06	5.33e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NOS3—systemic lupus erythematosus	5.95e-06	5.1e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—systemic lupus erythematosus	5.61e-06	4.8e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—systemic lupus erythematosus	5.44e-06	4.66e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	5.21e-06	4.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	5.09e-06	4.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—systemic lupus erythematosus	4.69e-06	4.01e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—EP300—systemic lupus erythematosus	4.53e-06	3.88e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	4.48e-06	3.84e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	4.1e-06	3.51e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—EP300—systemic lupus erythematosus	3.41e-06	2.92e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.21e-06	2.75e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.89e-06	2.47e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.76e-06	2.36e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.53e-06	2.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.1e-06	1.8e-05	CbGpPWpGaD
